Property of Dose Distribution in Accordance with Dose Rate Variation in Intensity Modulated Radiation Therapy |
Kang, Min-Kyu
(Department of Therapeutic Radiology & Oncology, College of Medicine, Yeungnam University)
Kim, Sung-Joon (Department of Therapeutic Radiology & Oncology, CHA Bundang Medical Center, CHA University) Shin, Hyun-Soo (Department of Therapeutic Radiology & Oncology, CHA Bundang Medical Center, CHA University) Kim, Sung-Kyu (Department of Therapeutic Radiology & Oncology, College of Medicine, Yeungnam University) |
1 | Zhu XR, Jursinic PA, Grimm DF: Evaluation of Kodak EDR2 film for dose verification of intensity modulated radiation therapy by a static multileaf collimator. Med Phys 29:1687-1692 (2002) DOI ScienceOn |
2 | Garden AS, Morrison WH, Rosenthal DI, Chao KSC, Ang KK: Target coverage for head and neck cancers treated with IMRT: review of clinical experiences. Seminars in Radiation Oncology 14:103-109 (2004) DOI ScienceOn |
3 | Yao M, Karnell LH, Funk GF, Lu H, Dornfeld K, Buatti JM: Health-related quality of life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 69:1354-1360 (2007) DOI ScienceOn |
4 | Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M, Ringash J: Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiotherapy and Oncology 89:287-291 (2008) DOI ScienceOn |
5 | Xia P, Chuang C, Verhey L: Communication and sampling rate limitations in IMRT with a dynamic multileaf collimator system. Med Phys 29:412-423 (2002) DOI ScienceOn |
6 | Fenoglietto P, Laliberte B, Allaw A, et al: Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiotherapy and Oncology 88:77-87 (2008) DOI ScienceOn |
7 | Garofalo MC, Nazareth DP, Errens M, D"fSouza W, Regine WF: A comparison of 3D-CRT and IMRT planning for patients with T3Nx or T4Nx Mid/Distal rectal cancers: potential for small bowel sparing and reductions in Dose-limiting acute GI toxicity. Int J Radiat Oncol Biol Phys 72:S250 (2008) |